Possible trazodone potentiation of fluoxetine: a case series
- PMID: 1548249
Possible trazodone potentiation of fluoxetine: a case series
Abstract
Background: Fluoxetine is an effective serotonin reuptake inhibitor antidepressant that can fail to alleviate either insomnia or major depression in a substantial minority of depressed patients. Trazodone has been reported to be both an effective nonbenzodiazepine hypnotic for antidepressant-associated insomnia and a possible serotonergic antidepressant adjunct. We present a case series of patients with variable responses when trazodone was added to fluoxetine.
Method: Eight consecutive depressed (DSM-III-R) patients taking fluoxetine were given trazodone either for sleep or as a possible antidepressant potentiator.
Results: Three (37.5%) of the eight patients (confidence interval = 4.0%-71.0%) had improvements in both sleep and depression. The remaining five patients either were unaffected by the addition of trazodone to fluoxetine or had intolerable adverse drug reactions.
Conclusion: Trazodone may be an effective hypnotic and antidepressant potentiator when combined with fluoxetine for some patients, but its use may be limited by adverse effects.
Similar articles
-
Fluoxetine versus trazodone: efficacy and activating-sedating effects.J Clin Psychiatry. 1991 Jul;52(7):294-9. J Clin Psychiatry. 1991. PMID: 2071559 Clinical Trial.
-
Obsessive compulsive disorder, depression, and fluoxetine.J Clin Psychiatry. 1991 Oct;52(10):418-22. J Clin Psychiatry. 1991. PMID: 1938978 Clinical Trial.
-
The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.J Clin Psychiatry. 1995 Aug;56(8):338-43. J Clin Psychiatry. 1995. PMID: 7635848 Clinical Trial.
-
Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.J Clin Psychopharmacol. 1987 Dec;7(6 Suppl):44S-49S. J Clin Psychopharmacol. 1987. PMID: 3123528 Review.
-
A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action.Psychopharmacology (Berl). 1992;109(1-2):2-11. doi: 10.1007/BF02245475. Psychopharmacology (Berl). 1992. PMID: 1365657 Review.
Cited by
-
Metabolism of some "second"- and "fourth"-generation antidepressants: iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine.Cell Mol Neurobiol. 1999 Aug;19(4):427-42. doi: 10.1023/a:1006953923305. Cell Mol Neurobiol. 1999. PMID: 10379419 Free PMC article. Review.
-
Rediscovering trazodone for the treatment of major depressive disorder.CNS Drugs. 2012 Dec;26(12):1033-49. doi: 10.1007/s40263-012-0010-5. CNS Drugs. 2012. PMID: 23192413 Free PMC article. Review.
-
Trazodone in the Management of Major Depression Among Elderly Patients with Dementia: A Narrative Review and Clinical Insights.Neuropsychiatr Dis Treat. 2023 Dec 21;19:2817-2831. doi: 10.2147/NDT.S434130. eCollection 2023. Neuropsychiatr Dis Treat. 2023. PMID: 38155994 Free PMC article.
-
Sequential psychological and pharmacological therapies for comorbid and primary insomnia: study protocol for a randomized controlled trial.Trials. 2016 Mar 3;17(1):118. doi: 10.1186/s13063-016-1242-3. Trials. 2016. PMID: 26940892 Free PMC article.
-
Update on augmentation of antidepressant response in resistant depression.Curr Psychiatry Rep. 2005 Dec;7(6):435-40. doi: 10.1007/s11920-005-0064-x. Curr Psychiatry Rep. 2005. PMID: 16318821 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources